Systemic comorbidities of dry eye syndrome

The Korean national health and nutrition examination survey V, 2010 to 2012

Hyun Cheol Roh, Jimmy K. Lee, Martha Kim, Jong Hyun Oh, Min Wook Chang, Roy S. Chuck, Choul Yong Park

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To identify systemic comorbidities in patients with dry eye syndrome in South Korea. Methods: From 2010 to 2012, 17,364 participants aged 20 or older were randomly included in the nationwide Korean National Health and Nutrition Examination Survey V. The prevalence of dry eye syndrome and demographics of these patients were investigated. We performed conditional logistic regression analyses based on age, sex, residential area, education level, occupation type, and household income level to obtain the odds ratio for each systemic comorbidity among subjects with and without dry eye syndrome. Results: The prevalence of dry eye syndrome in this study was 10.4%. Age [adjusted odds ratio (AOR): 1.02], female gender (AOR: 3.01), and indoor occupation (AOR: 1.30) were associated with a higher prevalence of dry eye syndrome and found to be less prevalent in those residing in rural areas (AOR: 0.73) and with lower education levels (AOR: 0.66-0.99). With regard to systemic comorbidities, dyslipidemia (AOR: 1.63), degenerative arthritis (AOR: 1.56), rheumatoid arthritis (AOR: 1.44), thyroid disease (AOR: 1.79), and renal failure (AOR: 2.56) were associated with a significantly higher prevalence of dry eye syndrome. Conclusions: We found that patients with dry eye syndrome have a higher prevalence of several systemic comorbidities. A more comprehensive therapeutic approach considering the effect of systemic medication may be necessary in these patients.

Original languageEnglish (US)
Pages (from-to)187-192
Number of pages6
JournalCornea
Volume35
Issue number2
DOIs
StatePublished - 2016

Fingerprint

Dry Eye Syndromes
Nutrition Surveys
Comorbidity
Odds Ratio
Occupations
Education
Republic of Korea
Thyroid Diseases
Dyslipidemias
Osteoarthritis
Renal Insufficiency
Rheumatoid Arthritis

Keywords

  • Comorbidity
  • Dry eye
  • KNHANES
  • Prevalence
  • Risk factor

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Systemic comorbidities of dry eye syndrome : The Korean national health and nutrition examination survey V, 2010 to 2012. / Roh, Hyun Cheol; Lee, Jimmy K.; Kim, Martha; Oh, Jong Hyun; Chang, Min Wook; Chuck, Roy S.; Park, Choul Yong.

In: Cornea, Vol. 35, No. 2, 2016, p. 187-192.

Research output: Contribution to journalArticle

Roh, Hyun Cheol ; Lee, Jimmy K. ; Kim, Martha ; Oh, Jong Hyun ; Chang, Min Wook ; Chuck, Roy S. ; Park, Choul Yong. / Systemic comorbidities of dry eye syndrome : The Korean national health and nutrition examination survey V, 2010 to 2012. In: Cornea. 2016 ; Vol. 35, No. 2. pp. 187-192.
@article{07ce7240ade04a81b885e139a411f73b,
title = "Systemic comorbidities of dry eye syndrome: The Korean national health and nutrition examination survey V, 2010 to 2012",
abstract = "Purpose: To identify systemic comorbidities in patients with dry eye syndrome in South Korea. Methods: From 2010 to 2012, 17,364 participants aged 20 or older were randomly included in the nationwide Korean National Health and Nutrition Examination Survey V. The prevalence of dry eye syndrome and demographics of these patients were investigated. We performed conditional logistic regression analyses based on age, sex, residential area, education level, occupation type, and household income level to obtain the odds ratio for each systemic comorbidity among subjects with and without dry eye syndrome. Results: The prevalence of dry eye syndrome in this study was 10.4{\%}. Age [adjusted odds ratio (AOR): 1.02], female gender (AOR: 3.01), and indoor occupation (AOR: 1.30) were associated with a higher prevalence of dry eye syndrome and found to be less prevalent in those residing in rural areas (AOR: 0.73) and with lower education levels (AOR: 0.66-0.99). With regard to systemic comorbidities, dyslipidemia (AOR: 1.63), degenerative arthritis (AOR: 1.56), rheumatoid arthritis (AOR: 1.44), thyroid disease (AOR: 1.79), and renal failure (AOR: 2.56) were associated with a significantly higher prevalence of dry eye syndrome. Conclusions: We found that patients with dry eye syndrome have a higher prevalence of several systemic comorbidities. A more comprehensive therapeutic approach considering the effect of systemic medication may be necessary in these patients.",
keywords = "Comorbidity, Dry eye, KNHANES, Prevalence, Risk factor",
author = "Roh, {Hyun Cheol} and Lee, {Jimmy K.} and Martha Kim and Oh, {Jong Hyun} and Chang, {Min Wook} and Chuck, {Roy S.} and Park, {Choul Yong}",
year = "2016",
doi = "10.1097/ICO.0000000000000657",
language = "English (US)",
volume = "35",
pages = "187--192",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Systemic comorbidities of dry eye syndrome

T2 - The Korean national health and nutrition examination survey V, 2010 to 2012

AU - Roh, Hyun Cheol

AU - Lee, Jimmy K.

AU - Kim, Martha

AU - Oh, Jong Hyun

AU - Chang, Min Wook

AU - Chuck, Roy S.

AU - Park, Choul Yong

PY - 2016

Y1 - 2016

N2 - Purpose: To identify systemic comorbidities in patients with dry eye syndrome in South Korea. Methods: From 2010 to 2012, 17,364 participants aged 20 or older were randomly included in the nationwide Korean National Health and Nutrition Examination Survey V. The prevalence of dry eye syndrome and demographics of these patients were investigated. We performed conditional logistic regression analyses based on age, sex, residential area, education level, occupation type, and household income level to obtain the odds ratio for each systemic comorbidity among subjects with and without dry eye syndrome. Results: The prevalence of dry eye syndrome in this study was 10.4%. Age [adjusted odds ratio (AOR): 1.02], female gender (AOR: 3.01), and indoor occupation (AOR: 1.30) were associated with a higher prevalence of dry eye syndrome and found to be less prevalent in those residing in rural areas (AOR: 0.73) and with lower education levels (AOR: 0.66-0.99). With regard to systemic comorbidities, dyslipidemia (AOR: 1.63), degenerative arthritis (AOR: 1.56), rheumatoid arthritis (AOR: 1.44), thyroid disease (AOR: 1.79), and renal failure (AOR: 2.56) were associated with a significantly higher prevalence of dry eye syndrome. Conclusions: We found that patients with dry eye syndrome have a higher prevalence of several systemic comorbidities. A more comprehensive therapeutic approach considering the effect of systemic medication may be necessary in these patients.

AB - Purpose: To identify systemic comorbidities in patients with dry eye syndrome in South Korea. Methods: From 2010 to 2012, 17,364 participants aged 20 or older were randomly included in the nationwide Korean National Health and Nutrition Examination Survey V. The prevalence of dry eye syndrome and demographics of these patients were investigated. We performed conditional logistic regression analyses based on age, sex, residential area, education level, occupation type, and household income level to obtain the odds ratio for each systemic comorbidity among subjects with and without dry eye syndrome. Results: The prevalence of dry eye syndrome in this study was 10.4%. Age [adjusted odds ratio (AOR): 1.02], female gender (AOR: 3.01), and indoor occupation (AOR: 1.30) were associated with a higher prevalence of dry eye syndrome and found to be less prevalent in those residing in rural areas (AOR: 0.73) and with lower education levels (AOR: 0.66-0.99). With regard to systemic comorbidities, dyslipidemia (AOR: 1.63), degenerative arthritis (AOR: 1.56), rheumatoid arthritis (AOR: 1.44), thyroid disease (AOR: 1.79), and renal failure (AOR: 2.56) were associated with a significantly higher prevalence of dry eye syndrome. Conclusions: We found that patients with dry eye syndrome have a higher prevalence of several systemic comorbidities. A more comprehensive therapeutic approach considering the effect of systemic medication may be necessary in these patients.

KW - Comorbidity

KW - Dry eye

KW - KNHANES

KW - Prevalence

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=84955348733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955348733&partnerID=8YFLogxK

U2 - 10.1097/ICO.0000000000000657

DO - 10.1097/ICO.0000000000000657

M3 - Article

VL - 35

SP - 187

EP - 192

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 2

ER -